40684511000001104: Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)
\UK product\Virtual medicinal product\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)
\UK product\Virtual therapeutic moiety\Irbesartan + Hydrochlorothiazide\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)
\UK product\Virtual therapeutic moiety\Irbesartan + Hydrochlorothiazide\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing angiotensin II receptor antagonist\Product containing irbesartan\Product containing irbesartan in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing angiotensin II receptor antagonist\Product containing irbesartan\Product containing hydrochlorothiazide and irbesartan\Irbesartan + Hydrochlorothiazide\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing angiotensin II receptor antagonist\Product containing irbesartan\Product containing hydrochlorothiazide and irbesartan\Irbesartan + Hydrochlorothiazide\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing angiotensin II receptor antagonist\Product containing irbesartan\Product containing hydrochlorothiazide and irbesartan\Product containing hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing angiotensin II receptor antagonist\Product containing irbesartan\Product containing irbesartan in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing angiotensin II receptor antagonist\Product containing irbesartan\Product containing hydrochlorothiazide and irbesartan\Irbesartan + Hydrochlorothiazide\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing angiotensin II receptor antagonist\Product containing irbesartan\Product containing hydrochlorothiazide and irbesartan\Irbesartan + Hydrochlorothiazide\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing angiotensin II receptor antagonist\Product containing irbesartan\Product containing hydrochlorothiazide and irbesartan\Product containing hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing irbesartan\Product containing irbesartan in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing irbesartan\Product containing hydrochlorothiazide and irbesartan\Irbesartan + Hydrochlorothiazide\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing irbesartan\Product containing hydrochlorothiazide and irbesartan\Irbesartan + Hydrochlorothiazide\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing azole\Product containing irbesartan\Product containing hydrochlorothiazide and irbesartan\Product containing hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and irbesartan\Irbesartan + Hydrochlorothiazide\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and irbesartan\Irbesartan + Hydrochlorothiazide\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing benzothiadiazine\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and irbesartan\Product containing hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and irbesartan\Irbesartan + Hydrochlorothiazide\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and irbesartan\Irbesartan + Hydrochlorothiazide\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by structure\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and irbesartan\Product containing hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and irbesartan\Irbesartan + Hydrochlorothiazide\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and irbesartan\Irbesartan + Hydrochlorothiazide\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as diuretic (product)\Medicinal product containing thiazide and acting as diuretic agent (product)\Product containing hydrochlorothiazide\Product containing hydrochlorothiazide and irbesartan\Product containing hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing irbesartan in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)
\Medicinal product\Product manufactured as oral dose form\Product containing hydrochlorothiazide in oral dose form (medicinal product form)\Product containing hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing only hydrochlorothiazide and irbesartan in oral dose form (medicinal product form)\Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet\Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Jun 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

2264971000001111 Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2264981000001113 Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)	Has excipient	Lactose	false	Inferred relationship	Existential restriction modifier
Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)	Is a	Product containing precisely hydrochlorothiazide 12.5 milligram and irbesartan 150 milligram/1 each conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)	Has specific active ingredient	Hydrochlorothiazide	true	Inferred relationship	Existential restriction modifier
Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)	Has specific active ingredient	Irbesartan	true	Inferred relationship	Existential restriction modifier
Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets	Has AMP	True	Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2264971000001111	Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
2264981000001113	Irbesartan 150mg / Hydrochlorothiazide 12.5mg tablets (Bristol Laboratories Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module